The Current Ratio as of September 2024 (TTM) for Miromatrix Medical Inc. (MIRO) is 3.46

According to Miromatrix Medical Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.46. This represents a change of -39.36% compared to the average of 5.71 of the last 4 quarters.

Miromatrix Medical Inc. (MIRO) Historical Current Ratio (quarterly & annually)

How has MIRO Current Ratio performed in the past?

The mean historical Current Ratio of Miromatrix Medical Inc. over the last ten years is 5.15. The current 3.46 Current Ratio has changed 6.62% with respect to the historical average. Over the past ten years (40 quarters), MIRO's Current Ratio was at its highest in in the June 2021 quarter at 27.16. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Miromatrix Medical Inc. (MIRO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Miromatrix Medical Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Miromatrix Medical Inc. (MIRO) Average Current Ratio

How has MIRO Current Ratio performed in the past?

The current Current Ratio of Miromatrix Medical Inc. (MIRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Miromatrix Medical Inc. (MIRO) Current Ratio vs. Peers

How is MIRO’s Current Ratio compared to its peers?

Miromatrix Medical Inc.’s Current Ratio is less than Anebulo Pharmaceuticals, Inc. (5.32), less than PMV Pharmaceuticals, Inc. (19.22), greater than ZIVO Bioscience, Inc. (0.17), less than Bionomics Limited (3.81), less than Molecular Partners AG (14.58), less than Mineralys Therapeutics, Inc. (11.20), less than AN2 Therapeutics, Inc. (10.61), less than Pharvaris N.V. (18.45), less than PepGen Inc. (7.45), greater than NervGen Pharma Corp. (1.78), less than Acrivon Therapeutics, Inc. Common Stock (16.16), greater than Protagenic Therapeutics, Inc. (2.03), greater than Inhibikase Therapeutics, Inc. (2.32), less than Eliem Therapeutics, Inc. (60.41), greater than HCW Biologics Inc. (0.10),

Build a custom stock screener for Miromatrix Medical Inc. (MIRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Miromatrix Medical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Miromatrix Medical Inc. (MIRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Miromatrix Medical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.